These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2448666)

  • 1. [Growth fraction of human central nervous system tumors measured by using bromodeoxyuridine].
    Yoshii Y; Maki Y; Matsuki T; Komatsu Y; Tsurushima H; Yamada Y; Higuchi O; Sugimoto K; Takeuchi S; Hoshino T
    Neurol Med Chir (Tokyo); 1987 Jun; 27(6):482-90. PubMed ID: 2448666
    [No Abstract]   [Full Text] [Related]  

  • 2. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T; Hoshino T
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative potential of pediatric brain tumors.
    Hoshino T
    Prog Exp Tumor Res; 1987; 30():31-43. PubMed ID: 3306799
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
    Nagashima T; DeArmond SJ; Murovic J; Hoshino T
    Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-kinetic characteristics of human brain tumors.
    Assietti R; Butti G; Magrassi L; Danova M; Riccardi A; Gaetani P
    Oncology; 1990; 47(4):344-51. PubMed ID: 2367061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.
    Kharbanda K; Dinda AK; Sarkar C; Karak AK; Dhir R; Mathur M; Roy S
    J Neurooncol; 1995; 23(3):185-90. PubMed ID: 7673980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetics of intracerebrally implanted RG-C6 tumors in rats--effects of intracarotid hyperosmolar mannitol measured by 3H-thymidine autoradiography and bromodeoxyuridine uptake.
    Inoue T; Iwaki T; Fukui M; Takeshita I
    Neurol Med Chir (Tokyo); 1988 Jun; 28(6):533-7. PubMed ID: 2460779
    [No Abstract]   [Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
    Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
    Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New development in clinicopathological diagnosis of brain tumors].
    Hoshino T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):160-7. PubMed ID: 1992908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin 1 and gliomas: immunohistochemical and immunocytochemical examinations].
    Tanaka S; Kamitani H; Hori T; Hirai Y; Nakai S; Kawai K
    No To Shinkei; 1988 Mar; 40(3):205-10. PubMed ID: 2840106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
    McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of labeling index of DNA polymerase alpha in human brain tumors. Comparative study with labeling indices of BUdR in vitro and Ki-67.
    Nishizaki T; Orita T; Kamiryo T; Akimura T; Kajiwara K; Ikeda N; Ohshita N; Ito H; Sasaki K
    Clin Neuropathol; 1993; 12(3):160-3. PubMed ID: 8324965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
    Zuber P; Hamou MF; de Tribolet N
    Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
    Oriuchi N; Tamura M; Shibazaki T; Inoue T; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Igarashi H; Endo K
    Kaku Igaku; 1991 Nov; 28(11):1263-71. PubMed ID: 1770641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kinetics of glial tumors.
    Hoshino T
    Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
    J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
    Shibata T; Burger PC; Kleihues P
    No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of invasiveness to proliferating activity and to cytoskeletal protein production in human neuroepithelial tumors maintained in an organ culture system: use of human cortex and dura as supporting matrices.
    Ibayashi N; Herman MM; Boyd JC; Rubinstein LJ
    Neurosurgery; 1990 Apr; 26(4):629-37. PubMed ID: 2109841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.